Health
Romanian Pharmaceutical Market Seen Up To 2% Higher In Value, Flat In Volume End-2013
Romania’s pharmaceutical market is expected to witness an increase of up to 2% in value and to stagnate in volume at the end of 2013, according to estimates by Dragos Damian, president of th...
MedLife's 2014 Plans: Clinics In All Major Cities And Health Card
The next year "looks like it will be a good year" for MedLife, according to chairman Mihai Marcu, whose main two projects for 2014 are expansion to all major cities and implementation of a h...
Antibiotice Iasi: Exports Reach 30% Of 2013 Sales
Health Ministry-owned drug producer Antibiotice Iasi (ATB.RO) estimates this year's exports to amount to more than $26 million or 30% of its total sales.
How GSK Decided To Give Up Its Plant In Brasov
The announcement of British drugmaker GlaxoSmithKline (GSK) about giving up its Europharm plant in Brasov, central Romania, came as a shock to the pharmaceutical industry this summer.
Europharm Distributie Expands Depot In Chitila, Closes Brasov Unit End-December
Romanian pharmaceutical wholesaler Europharm Distributie, owned by UK group GlaxoSmithKline (GSK), has extended its warehouse in Chitila by more than 2,000 square meters to integrate the act...
Three Low-Profile Execs Have EUR17B Of Romania’s Budget In Their Hands
The institutions in charge of pensions, health insurance and highways, which have total budgets of over EUR17 billion, are run by three executives who have been politically appointed by ruli...
GSK Hopes To Select Buyer For Its Medicines Factory In Brasov By End 1Q/2014
British pharmaceutical group GlaxoSmithKline (GSK) Thursday said it expects to select a buyer for its medicines production line in Brasov, central Romania, by the end of the first quarter in...
Bayer Is Optimistic About Romania’s Economic Growth
German conglomerate Bayer is optimistic about Romania, as the country is expected to see annual economic growth of 3% to 4% by 2018, said Andreas Schremmer, managing director of Bayer Romani...
IMS Health: Romanian Pharmaceutical Market Rose 6% To RON9.3B In January-September
The Romanian pharmaceutical market rose 6% in the first nine months of 2013 to 9.33 billion lei (EUR2.11 billion), according to market research company IMS Health.